We are live on ! Find out more
ACET icon

Adicet Bio
ACET

56 hedge funds and large institutions have $42M invested in Adicet Bio in 2025 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 12 increasing their positions, 22 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

143% more call options, than puts

Call options by funds: $34K | Put options by funds: $14K

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0.15% less ownership

Funds ownership: 4.37% → 4.22% (-0.15%)

13% less funds holding

Funds holding: 64 → 56 (-8)

24% less capital invested

Capital invested by funds: $55.4M → $42M (-$13.4M)

45% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 22

67% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 12

Holders
56
Holders Change
-8
Holders Change %
-12.5%
% of All Funds
0.75%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
4
Increased
12
Reduced
22
Closed
12
Calls
$34K
Puts
$14K
Net Calls
+$20K
Net Calls Change
+$45K

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$1.1M
2
WIA
Wealthedge Investment Advisors
New York
+$138K
3
TCM
Tang Capital Management
California
+$69.4K
4
Goldman Sachs
Goldman Sachs
New York
+$56.9K
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$32.4K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$528K
2
Norges Bank
Norges Bank
Norway
-$413K
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$305K
4
Two Sigma Investments
Two Sigma Investments
New York
-$186K
5
SCM
Stonepine Capital Management
Oregon
-$171K
Name Holding Trade Value Shares
Change 		Change in
Stake
JP Morgan Chase
51
JP Morgan Chase
New York
$883 -$133K -9,332 -99%
HCM
52
Hollencrest Capital Management
California
$680 – – –
BNP Paribas Financial Markets
53
BNP Paribas Financial Markets
France
$675 – – –
SS
54
SBI Securities
Japan
$577 +$529 +37 +336%
PD
55
Point72 (DIFC)
United Arab Emirates
$72 – – –
TIM
56
Thompson Investment Management
Wisconsin
$60 – – –
Norges Bank
57
Norges Bank
Norway
– -$413K -26,847 Closed
ETC
58
Exchange Traded Concepts
Oklahoma
– -$107K -6,978 Closed
DC
59
Diametric Capital
Massachusetts
– -$82.3K -5,345 Closed
XT
60
XTX Topco
Cayman Islands
– -$65.6K -4,262 Closed
Connor, Clark & Lunn Investment Management (CC&L)
61
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
– -$49.2K -3,198 Closed
CP
62
Castleview Partners
Texas
– -$46.6K -2,994 Closed
Marshall Wace
63
Marshall Wace
United Kingdom
– -$38.7K -2,519 Closed
GCP
64
GSA Capital Partners
United Kingdom
– -$16K -1,048 Closed
PNC Financial Services Group
65
PNC Financial Services Group
Pennsylvania
– -$162 -11 Closed
Barclays
66
Barclays
United Kingdom
– -$13 -1 Closed
1 2
3

ACET Hedge Fund Activity: Q1 2025 in Review

56 of the 7,461 institutional investors tracked by Wall St. Rank reported a position in Adicet Bio (ACET) for Q1 2025, worth a combined $42M — down 24% from $55.4M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of ACET and 4 opened new positions — a net loss of 8 holders — while 22 trimmed existing stakes and 12 added.

The largest buyer was Citadel Advisors, adding an estimated $1.1M. The largest seller was Millennium Management, cutting an estimated $528K.

  • 56 institutional investors held Adicet Bio (ACET) as of Q1 2025, down from 64 in Q4 2024.
  • Funds reported $42M of Adicet Bio stock for Q1 2025, down 24% quarter-over-quarter.
  • 4 funds opened new Adicet Bio positions in Q1 2025 and 12 closed out, a net change of -8 holders.
  • The largest Adicet Bio buyer in Q1 2025 was Citadel Advisors, an estimated $1.1M added.
  • The largest Adicet Bio seller in Q1 2025 was Millennium Management, an estimated $528K sold.

Based on aggregated 13F filings for Q1 2025.